Your browser doesn't support javascript.
loading
Inflammatory breast cancer cells are characterized by abrogated TGFß1-dependent cell motility and SMAD3 activity.
Rypens, Charlotte; Marsan, Melike; Van Berckelaer, Christophe; Billiet, Charlotte; Melis, Kirsten; Lopez, Sara Perez; van Dam, Peter; Devi, Gayathri R; Finetti, Pascal; Ueno, Naoto T; Bertucci, François; Dirix, Piet; Neven, Patrick; Vermeulen, Peter; Dirix, Luc; Van Laere, Steven J.
Afiliação
  • Rypens C; Center for Oncological Research (CORE), Faculty of Medicine and Health Sciences - University of Antwerp, Campus Drie Eiken - Universiteitsplein 1, 2610, Wilrijk - Antwerp, Belgium. charlotte.rypens@uantwerpen.be.
  • Marsan M; Translational Cancer Research Unit (TCRU), GZA Ziekenhuizen campus Sint-Augustinus, Oosterveldlaan 24, 2610, Wilrijk - Antwerp, Belgium. charlotte.rypens@uantwerpen.be.
  • Van Berckelaer C; Translational Cancer Research Unit (TCRU), GZA Ziekenhuizen campus Sint-Augustinus, Oosterveldlaan 24, 2610, Wilrijk - Antwerp, Belgium.
  • Billiet C; Center for Oncological Research (CORE), Faculty of Medicine and Health Sciences - University of Antwerp, Campus Drie Eiken - Universiteitsplein 1, 2610, Wilrijk - Antwerp, Belgium.
  • Melis K; Translational Cancer Research Unit (TCRU), GZA Ziekenhuizen campus Sint-Augustinus, Oosterveldlaan 24, 2610, Wilrijk - Antwerp, Belgium.
  • Lopez SP; Multidisciplinary Breast Clinic, Unit Gynaecologic Oncology, Antwerp University Hospital (UZA), Antwerp, Belgium.
  • van Dam P; Center for Oncological Research (CORE), Faculty of Medicine and Health Sciences - University of Antwerp, Campus Drie Eiken - Universiteitsplein 1, 2610, Wilrijk - Antwerp, Belgium.
  • Devi GR; Radiation Oncology, Iridium Kankernetwerk, Oosterveldlaan 24, 2610, Wilrijk - Antwerp, Belgium.
  • Finetti P; Karel de Grote Hogeschool, Antwerp, Belgium.
  • Ueno NT; University Complutense, Madrid, Spain.
  • Bertucci F; Center for Oncological Research (CORE), Faculty of Medicine and Health Sciences - University of Antwerp, Campus Drie Eiken - Universiteitsplein 1, 2610, Wilrijk - Antwerp, Belgium.
  • Dirix P; Multidisciplinary Breast Clinic, Unit Gynaecologic Oncology, Antwerp University Hospital (UZA), Antwerp, Belgium.
  • Neven P; Division of Surgical Sciences, Department of Surgery, Duke University Medical Sciences, Durham, NC, USA.
  • Vermeulen P; Predictive Oncology Team, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, CNRS, Aix-Marseille Université, Institut Paoli-Calmettes, Marseille, France.
  • Dirix L; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic & Department of Breast Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Van Laere SJ; Predictive Oncology Team, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, CNRS, Aix-Marseille Université, Institut Paoli-Calmettes, Marseille, France.
Breast Cancer Res Treat ; 180(2): 385-395, 2020 Apr.
Article em En | MEDLINE | ID: mdl-32043194

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Regulação Neoplásica da Expressão Gênica / Movimento Celular / Proteínas Proto-Oncogênicas c-myc / Proteína Smad3 / Fator de Crescimento Transformador beta1 / Neoplasias Inflamatórias Mamárias / Transição Epitelial-Mesenquimal Limite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Bélgica

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Regulação Neoplásica da Expressão Gênica / Movimento Celular / Proteínas Proto-Oncogênicas c-myc / Proteína Smad3 / Fator de Crescimento Transformador beta1 / Neoplasias Inflamatórias Mamárias / Transição Epitelial-Mesenquimal Limite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Bélgica